CL
GMAB icon

CIM LLC’s Genmab GMAB Stock Holding History

CIM LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,268
Closed -$856K – 157
2023
Q3 		$856K Buy
24,268
+189
+0.8% +$7.2K 0.16% 89
2023
Q2 		$915K Sell
24,079
-2,861
-11% -$114K 0.17% 91
2023
Q1 		$1.02M Buy
26,940
+63
+0.2% +$2.42K 0.2% 78
2022
Q4 		$1.07M Sell
26,877
-3,139
-10% -$129K 0.21% 78
2022
Q3 		$1.15M Sell
30,016
-49
-0.2% -$1.72K 0.24% 73
2022
Q2 		$1.03M Buy
30,065
+2,071
+7% +$67.1K 0.21% 76
2022
Q1 		$1M Buy
27,994
+465
+2% +$16K 0.19% 81
2021
Q4 		$897K Sell
27,529
-3,924
-12% -$164K 0.17% 83
2021
Q3 		$1.46M Buy
31,453
+770
+3% +$34.6K 0.23% 71
2021
Q2 		$1.4M Buy
30,683
+178
+0.6% +$6.87K 0.23% 67
2021
Q1 		$1.14M Buy
30,505
+1,257
+4% +$47.3K 0.2% 77
2020
Q4 		$1.19M Buy
29,248
+511
+2% +$19.1K 0.22% 64
2020
Q3 		$1.13M Sell
28,737
-860
-3% -$31.1K 0.23% 57
2020
Q2 		$1M Buy
+29,597
New +$807K 0.29% 47

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIM LLC's GMAB Position: Q4 2023 in Review

CIM LLC sold out of Genmab (GMAB) in Q4 2023, closing a stake of 24,268 shares — an estimated $856K sold.

CIM LLC first reported a position in GMAB in Q2 2020 and held it in 14 quarters. The position peaked at $1.46M in Q3 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • CIM LLC reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • CIM LLC sold 24,268 Genmab shares in Q4 2023, an estimated $856K.
  • CIM LLC first reported a position in Genmab in Q2 2020 and held it in 14 quarters.
  • CIM LLC's Genmab position peaked at $1.46M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on CIM LLC's 13F filing for Q4 2023, filed 23 Feb 2024.